Taiwan · Delayed Price · Currency is TWD Health & Life Statistics
Total Valuation
Health & Life has a market cap or net worth of TWD 514.37 million. The enterprise value is 489.92 million.
| Market Cap | 514.37M |
| Enterprise Value | 489.92M |
Important Dates
The next estimated earnings date is Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Health & Life has 47.41 million shares outstanding. The number of shares has decreased by -0.21% in one year.
| Current Share Class | 47.41M |
| Shares Outstanding | 47.41M |
| Shares Change (YoY) | -0.21% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 23.56% |
| Owned by Institutions (%) | n/a |
| Float | 35.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.29 |
| PB Ratio | 1.70 |
| P/TBV Ratio | 1.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.71, with a Debt / Equity ratio of 0.65.
| Current Ratio | 2.71 |
| Quick Ratio | 1.86 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | n/a |
| Debt / FCF | -8.12 |
| Interest Coverage | -12.96 |
Financial Efficiency
Return on equity (ROE) is -15.59% and return on invested capital (ROIC) is -27.32%.
| Return on Equity (ROE) | -15.59% |
| Return on Assets (ROA) | -7.02% |
| Return on Invested Capital (ROIC) | -27.32% |
| Return on Capital Employed (ROCE) | -15.00% |
| Weighted Average Cost of Capital (WACC) | 4.46% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.60 |
| Inventory Turnover | 3.16 |
Taxes
In the past 12 months, Health & Life has paid 1.74 million in taxes.
| Income Tax | 1.74M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.53% in the last 52 weeks. The beta is 0.19, so Health & Life's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | -21.53% |
| 50-Day Moving Average | 11.58 |
| 200-Day Moving Average | 11.68 |
| Relative Strength Index (RSI) | 30.00 |
| Average Volume (20 Days) | 16,312 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Health & Life had revenue of TWD 400.09 million and -50.67 million in losses. Loss per share was -1.07.
| Revenue | 400.09M |
| Gross Profit | 54.88M |
| Operating Income | -75.04M |
| Pretax Income | -48.93M |
| Net Income | -50.67M |
| EBITDA | -65.27M |
| EBIT | -75.04M |
| Loss Per Share | -1.07 |
Balance Sheet
The company has 222.42 million in cash and 197.97 million in debt, with a net cash position of 24.45 million or 0.52 per share.
| Cash & Cash Equivalents | 222.42M |
| Total Debt | 197.97M |
| Net Cash | 24.45M |
| Net Cash Per Share | 0.52 |
| Equity (Book Value) | 303.23M |
| Book Value Per Share | 6.40 |
| Working Capital | 265.90M |
Cash Flow
In the last 12 months, operating cash flow was -16.59 million and capital expenditures -7.78 million, giving a free cash flow of -24.37 million.
| Operating Cash Flow | -16.59M |
| Capital Expenditures | -7.78M |
| Depreciation & Amortization | 9.77M |
| Net Borrowing | -15.60M |
| Free Cash Flow | -24.37M |
| FCF Per Share | -0.51 |
Margins
Gross margin is 13.72%, with operating and profit margins of -18.76% and -12.66%.
| Gross Margin | 13.72% |
| Operating Margin | -18.76% |
| Pretax Margin | -12.23% |
| Profit Margin | -12.66% |
| EBITDA Margin | -16.31% |
| EBIT Margin | -18.76% |
| FCF Margin | n/a |
Dividends & Yields
Health & Life does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.21% |
| Shareholder Yield | 0.21% |
| Earnings Yield | -9.85% |
| FCF Yield | -4.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 14, 2006. It was a forward split with a ratio of 1.0314.
| Last Split Date | Sep 14, 2006 |
| Split Type | Forward |
| Split Ratio | 1.0314 |
Scores
Health & Life has an Altman Z-Score of 1.39 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.39 |
| Piotroski F-Score | 1 |